D

Detroit Clinical Research Center | Farmington Hills, MI

Research site
(Unclaimed)
Location
30160 Orchard Lake Road, Farmington Hills, Michigan, United States of America
Site insights

Top conditions

Colitis (2 trials)

Ulcer (2 trials)

Breast Cancer (2 trials)

Non-Small-Cell Lung Carcinoma (2 trials)

Lung Cancer (2 trials)

Top treatments

RHB-105
Milvexian
Droxidopa
Farletuzumab
EG12014
Platinum
Abraxane
Carboplatin
LY3454738
Guselkumab

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

4 of 20
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (ASTRO)

The purpose of this study is to evaluate the efficacy, including clinical remission of guselkumab subcutaneous (SC) induction compared to placebo in...

Active, not recruiting
Colitis, Ulcerative
Other: Placebo
Drug: Guselkumab Dose 1

The purpose of this study is to evaluate whether milvexian compared to placebo reduce the risk of recurrent ischemic stroke.

Enrolling
Ischemic Stroke; Ischemic Attack, Transient
Drug: Placebo
Drug: Milvexian

The study is a prospective, randomized controlled phase III trial aimed to test the efficacy and safety of TTFields, using the NovoTTF-200T device, c...

Active, not recruiting
Nonsmall Cell Lung Cancer
NSCLC
Drug: Immune checkpoint inhibitors or docetaxel
Device: NovoTTF-200T

The main purpose of this open-label, dose-escalation, phase Ib study is to identify the appropriate dose of MEN1611 to be used in combination with Tr...

Active, not recruiting
Advanced or Metastatic Breast Cancer
Drug: Fulvestrant
Drug: MEN1611

Trial sponsors

Celgene logo

Celgene (2 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems